The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models

Brown, 1993, Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-d-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma, J. Nucl. Med., 34, 75 Brown, 1995, The intratumoral distribution of 3H-FDG and expression of glucose transporter-1 (Glut-1) are correlated in syngeneic breast carcinoma, J. Nucl. Med., 36, 61P Brown, 1993, Overexpression of Glut-1 glucose transporter in human breast cancer: An immunohistochemical study, Cancer, 72, 2979, 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X Bustamante, 1981, Energy metabolism of tumor cells: Requirement for a form of hexokinase with a propensity for mitochondrial binding, J. Biol. Chem., 256, 8699, 10.1016/S0021-9258(19)68900-3 Carlin, 1994, Diseased cells and pH, Med. Hypotheses, 42, 299, 10.1016/0306-9877(94)90003-5 Clavo, 1995, Hypoxia-induced increases in tumor FDG accumulation are associated with increased GLUT-1 expression and increased membrane glucose transport, J. Nucl. Med., 36, 62P Coleman, 1991, Single photon emission tomography in cancer imaging, Cancer, 67, 1261, 10.1002/1097-0142(19910215)67:4+<1261::AID-CNCR2820671524>3.0.CO;2-L Dexter, 1982, Inhibition of the growth of human colon cancer xenografts by polar solvents, Cancer Res., 42, 5018 Di Chiro, 1982, Glucose utilization of cerebral gliomas measured by 18F-fluorodeoxyglucose and positron emission tomography, Neurology, 32, 1323, 10.1212/WNL.32.12.1323 Fukumoto, 1989, Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues, J. Biol. Chem., 264, 7776, 10.1016/S0021-9258(18)83106-4 Gallager, 1978, Metabolic trapping as a principle of radiopharmaceutical design: Some factors responsible for the biodistribution of [18F]2-deoxy-2-d-glucose, J. Nucl. Med., 19, 1154 Goldin, 1981, Current results of the screening program at the division of cancer treatment, National Cancer Institute, Eur. J. Cancer, 17, 129, 10.1016/0014-2964(81)90027-X Harguindey, 1992, The Na+H+ antiporter in oncology in the light of the spontaneous regression of cancer and cell metabolism, Med. Hypotheses, 39, 229, 10.1016/0306-9877(92)90114-R Hatanaka, 1970, Evidence for a functional change in the plasma membrane of murine sarcoma virus-infected mouse embryo cells: Transport and transport-associated phosphorylation of 14C-2-deoxy-d-glucose, J. Biol. Chem., 245, 714, 10.1016/S0021-9258(18)63321-6 Hawkins, 1988, Applications of PET in clinical oncology, Cancer Metastasis Rev., 7, 119, 10.1007/BF00046482 Hers, 1992, Regulation of glucokinase and its role in liver metabolism, Trends Biochem., 17, 59, 10.1016/0968-0004(92)90500-9 Jorgenson, 1980, Multifunctional glucose-6-phosphatase studied in permeable isolated hepatocytes, J. Biol. Chem., 255, 5907, 10.1016/S0021-9258(19)70717-0 LeFevre, 1951, Active transport into the human erythrocyte: Evidence from comparative kinetics and competition of monosaccharides, J. Gen. Physiol., 34, 515, 10.1085/jgp.34.5.515 Nelson, 1996, Targeting glucose transport proteins for tumor imaging: Is it feasible?, J. Nucl. Med. Nelson, 1995, Regional upregulation of glucose transport proteins and 2-deoxyglucose retention, Q. J. Nucl. Med., 39, 36 Nishioka, 1992, Distribution of the glucose transporters in human brain tumors, Cancer Res., 52, 3972 Nordlie, 1971, Glucose-6-phosphatase-phosphotransferase: Roles and regulation in relation to gluconeogenesis, 543, 10.1016/S1874-6047(08)60382-0 Paul, 1985, Tumor localization with 18-2-fluoro-2-deoxy-d-glucose: Comparative autoradiography, glucose-6-phosphatase histochemistry and histology of renally implanted sarcoma of the rat, Res. Exp. Med., 185, 87, 10.1007/BF01854893 Perona, 1988, Increased pH and tumorigenicity of fibroblasts expressing a yeast proton pump, Nature, 334, 438, 10.1038/334438a0 Reinwein, 1957, Transport of glucose and other sugars across the cell membrane of the human erythrocyte, 16, 237 Singh, 1981, Vanadate: A potent inhibitor of multifunctional glucose-6-phosphatase, Biochem. Biophys. Acta, 678, 477, 10.1016/0304-4165(81)90129-X Solheim, 1980, pH Kinetic studies of bovine brain hexokinase, Biochemistry, 19, 6074, 10.1021/bi00567a020 Stetten, 1965, Metabolism of inorganic pyrophosphate, J. Biol. Chem., 240, 2248, 10.1016/S0021-9258(18)97454-5 Strauss, 1991, The applications of PET in clinical oncology, J. Nucl. Med., 32, 623 Weber, 1977, Enzymology of cancer cells, N. Engl. J. Med., 296, 541, 10.1056/NEJM197703102961005 Yamamoto, 1990, Over-expression of facilitative glucose transporter genes in human cancer, Biochem. Biophys. Res. Commun., 170, 223, 10.1016/0006-291X(90)91263-R Yonekura, 1982, Increased accumulation of 2-deoxy-2-(18F)fluoro-d-glucose in liver metastases from colon carcinoma, J. Nucl. Med., 23, 1133